The US spends twice as much on health per person as other high-income nations. Health expenditures per person reached $13,432 in 2023, which was over $3,700 more than any other peer nation.
According to the Commonwealth Fund, “reductions in administrative burdens and drug costs could substantially reduce the difference between U.S. and peer nation health spending.” However, the US continues to struggle with opaque pricing structures that harm patients and providers alike.
The Centers for Medicare & Medicaid Services (CMS) hospital first took steps to address this with the introduction of the hospital price transparency law in 2021. The aim was to give patients and providers access to clear pricing information in order to reduce inflated costs. But in practice, the initiative has been hindered by inconsistent execution and a lack of enforcement.
The recent CMS Request for Information (RFI) on Hospital Price Transparency (HPT) is a sign that the agency is actively evaluating how to close up loopholes and make these regulations more coherent.
At PurpleLab, we welcomed the opportunity to respond to the RFI and share our perspective. As a healthcare data platform deeply engaged in parsing and analyzing hospital pricing files, we understand both the promise and the current pitfalls of this data.
Our aim in responding was to help make the system better for everyone, from regulators to hospitals to patients.
Hospitals are under increasing pressure to comply with these regulations, but the bar for compliance is higher than many realize.
CMS proposed updates for Hospital Price Transparency regulations in the 2025 CY 2026 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems rule.
If these provisions are finalized, hospitals will be required to represent payer-specific negotiated charges more accurately, use EDI 835 Remittances as the only data source to improve calculation of allowed amounts, and standardize facility identification through use of the National Provider Identifier (NPI).
These changes will ensure that pricing information is standardized and easily comparable across hospitals and health plans – the goal of Executive Order 14221.
However, our internal analysis shows that nearly 40% of hospitals are still out of compliance, either because their files are missing, formatted incorrectly, or simply unreadable by CMS’s own validation tools.
Among the remaining 60% of hospitals that have posted the required files, a range of issues make it difficult (and sometimes impossible) to process their prices via automated routes.
Here are a few common examples of what we see in the field:
In our RFI comments, we focused on practical and scalable recommendations that can help the healthcare ecosystem move forward:
We also urged CMS to take a more proactive enforcement stance. As long as penalties are rare and random, compliance will remain uneven. But by working with industry experts to audit and validate data programmatically, CMS can ensure better compliance – without increasing burden.
How This Fits Into the Bigger Picture
The HPT initiative doesn’t exist in isolation. CMS is also exploring reforms around prescription drug pricing, PBM transparency, and bundled payment models like TEAM (Transforming Episode Accountability Model). Taken together, these efforts show that the agency is pushing for comprehensive price accountability across the system.
For hospitals, this means transparency is no longer optional, and incomplete data is no longer good enough. In fact, if your data isn’t up to scratch, it’s probably a sign that the organization isn’t ready for the next generation of value-based care.
So, how should hospitals respond? Think beyond compliance. Use transparency as a way to gain operational insight and guide strategic planning.
At PurpleLab, we’ve partnered with Payerset – the leader in enterprise price transparency – to offer Trusted Price Intelligence, a solution built for hospital leaders who want more than just a file on a website.
With this combined solution, hospitals can:
Reach out today to learn how Trusted Price Intelligence can turn regulatory complexity into actionable strategy.